119 related articles for article (PubMed ID: 32495033)
21. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer.
Panchal JM; Lairson DR; Chan W; Du XL
Clin Colorectal Cancer; 2013 Jun; 12(2):113-21. PubMed ID: 23137529
[TBL] [Abstract][Full Text] [Related]
22. Palliative radiation before hospice: the long and the short of it.
Yeung HN; Mitchell WM; Roeland EJ; Xu B; Mell LK; Le QT; Murphy JD
J Pain Symptom Manage; 2014 Dec; 48(6):1070-9. PubMed ID: 24819083
[TBL] [Abstract][Full Text] [Related]
23. High-intensity end-of-life care among Medicare beneficiaries with bladder cancer.
Hugar LA; Yabes JG; Filippou P; Wulff-Burchfield EM; Lopa SH; Gore J; Davies BJ; Jacobs BL
Urol Oncol; 2021 Oct; 39(10):731.e17-731.e24. PubMed ID: 33676849
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the Time to Palliative Care Referrals in Patients With Small-Cell Lung Cancer: A Single-Centre Retrospective Review.
Watson GA; Saunders J; Coate L
Am J Hosp Palliat Care; 2018 Nov; 35(11):1426-1432. PubMed ID: 29739231
[TBL] [Abstract][Full Text] [Related]
25. Inpatient Palliative Care Use Among Critically III Brain Metastasis Patients in the United States.
Rubens M; Ramamoorthy V; Saxena A; McGranaghan P; Bhatt C; Das S; Shehadeh N; Veledar E; Viamonte-Ros A; Odia Y; Mehta MP; Kotecha R
Am J Clin Oncol; 2020 Nov; 43(11):806-812. PubMed ID: 32804776
[TBL] [Abstract][Full Text] [Related]
26. Trends in end-of-life care and health care spending in women with uterine cancer.
Margolis B; Chen L; Accordino MK; Clarke Hillyer G; Hou JY; Tergas AI; Burke WM; Neugut AI; Ananth CV; Hershman DL; Wright JD
Am J Obstet Gynecol; 2017 Oct; 217(4):434.e1-434.e10. PubMed ID: 28709581
[TBL] [Abstract][Full Text] [Related]
27. Intensity of end-of-life health care and mortality after systemic anti-cancer treatment in patients with advanced lung cancer.
Oselin K; Pisarev H; Ilau K; Kiivet RA
BMC Cancer; 2021 Mar; 21(1):274. PubMed ID: 33722202
[TBL] [Abstract][Full Text] [Related]
28. Factors Associated With Use of High-Cost Agents for the Treatment of Metastatic Non-Small Cell Lung Cancer.
Bradley CJ; Eguchi M; Perraillon MC
J Natl Cancer Inst; 2020 Aug; 112(8):802-809. PubMed ID: 31710664
[TBL] [Abstract][Full Text] [Related]
29. Temporal and Geographic Variation in the Incidence of Alzheimer's Disease Diagnosis in the US between 2007 and 2014.
Kirson NY; Meadows ES; Desai U; Smith BP; Cheung HC; Zuckerman P; Matthews BR
J Am Geriatr Soc; 2020 Feb; 68(2):346-353. PubMed ID: 31797361
[TBL] [Abstract][Full Text] [Related]
30. Variability in access to hospital palliative care in the United States.
Goldsmith B; Dietrich J; Du Q; Morrison RS
J Palliat Med; 2008 Oct; 11(8):1094-102. PubMed ID: 18831653
[TBL] [Abstract][Full Text] [Related]
31. INITIAL ADOPTION OF RECOMBINANT HUMAN THYROID-STIMULATING HORMONE FOLLOWING THYROIDECTOMY IN THE MEDICARE THYROID CANCER PATIENT POPULATION.
Dinan MA; Li Y; Reed SD; Sosa JA
Endocr Pract; 2019 Jan; 25(1):31-42. PubMed ID: 30383499
[TBL] [Abstract][Full Text] [Related]
32. Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are not.
Brule SY; Al-Baimani K; Jonker H; Zhang T; Nicholas G; Goss G; Laurie SA; Wheatley-Price P
Lung Cancer; 2016 Jul; 97():15-21. PubMed ID: 27237022
[TBL] [Abstract][Full Text] [Related]
33. Indicators for early assessment of palliative care in lung cancer patients: a population study using linked health data.
Kelly M; O'Brien KM; Lucey M; Clough-Gorr K; Hannigan A
BMC Palliat Care; 2018 Feb; 17(1):37. PubMed ID: 29482533
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer.
Robinson TJ; Dinan MA; Li Y; Lee WR; Reed SD
J Palliat Med; 2015 Nov; 18(11):933-9. PubMed ID: 26241733
[TBL] [Abstract][Full Text] [Related]
35. Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer.
Nieder C; Tollåli T; Haukland E; Reigstad A; Flatøy LR; Engljähringer K
Support Care Cancer; 2016 Oct; 24(10):4385-91. PubMed ID: 27209479
[TBL] [Abstract][Full Text] [Related]
36. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.
Ailawadhi S; Frank RD; Sharma M; Menghani R; Temkit M; Paulus S; Khera N; Hashmi S; Advani P; Swaika A; Paulus A; Aslam N; Sher T; Roy V; Colon-Otero G; Chanan-Khan A
Cancer; 2018 Apr; 124(8):1710-1721. PubMed ID: 29360160
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of palliative care services: A population-based study of end-of-life care for cancer patients.
De Palma R; Fortuna D; Hegarty SE; Louis DZ; Melotti RM; Moro ML
Palliat Med; 2018 Sep; 32(8):1344-1352. PubMed ID: 29886795
[TBL] [Abstract][Full Text] [Related]
38. Use of Palliative Care Among Commercially Insured Patients With Metastatic Cancer Between 2001 and 2016.
Ferrario A; Zhang F; Ross-Degnan D; Wharam JF; Twaddle ML; Wagner AK
JCO Oncol Pract; 2022 May; 18(5):e677-e687. PubMed ID: 34986008
[TBL] [Abstract][Full Text] [Related]
39. Use of Inpatient Palliative Care Services in Patients With Advanced Cancer Receiving Critical Care Therapies.
Loh KP; Abdallah M; Shieh MS; Stefan MS; Pekow PS; Lindenauer PK; Mohile SG; Babu D; Lagu T
J Natl Compr Canc Netw; 2018 Sep; 16(9):1055-1064. PubMed ID: 30181417
[No Abstract] [Full Text] [Related]
40. End-of-life patterns of symptom management and cancer-directed care among Medicare beneficiaries with lung cancer: a claims-based analysis.
Davidoff AJ; Canavan ME; Prsic E; Saphire M; Wang SY; Presley CJ
Support Care Cancer; 2021 Jul; 29(7):3921-3932. PubMed ID: 33389087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
